chlorambucil and carboplatin

chlorambucil has been researched along with carboplatin in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19902 (50.00)18.7374
1990's1 (25.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Atkinson, R; Cassidy, L; Cordiner, J; Cruickshank, D; Davis, J; Duncan, ID; Fullerton, W; Kaye, SB; Mill, L; Rankin, EM1
Calvert, AH; De Stavola, B; Freedman, LS; Goodman, S; Hall, RR; Kaye, S; Rogers, AC1
Duncan, I; Harding, M; Kaye, SB; Kennedy, J; Kennedy, R; MacLean, A; Mill, L; Soukop, M1
Aldrich-Wright, JR; Aputen, AD; Elias, MG; Gilbert, J; Gordon, CP; Sakoff, JA; Scott, KF1

Trials

1 trial(s) available for chlorambucil and carboplatin

ArticleYear
A randomised study comparing standard dose carboplatin with chlorambucil and carboplatin in advanced ovarian cancer.
    British journal of cancer, 1992, Volume: 65, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chlorambucil; Drug Administration Schedule; Female; Humans; Leukopenia; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Survival Analysis; Thrombocytopenia

1992

Other Studies

3 other study(ies) available for chlorambucil and carboplatin

ArticleYear
Phase II trials in metastatic bladder cancer.
    Lancet (London, England), 1986, May-03, Volume: 1, Issue:8488

    Topics: Aged; Antineoplastic Agents; Carboplatin; Chlorambucil; Drug Evaluation; Humans; Neoplasm Metastasis; Organoplatinum Compounds; Urinary Bladder Neoplasms

1986
A pilot study of carboplatin (JM8, CBDCA) and chlorambucil in combination for advanced ovarian cancer.
    British journal of cancer, 1988, Volume: 58, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Chlorambucil; Female; Humans; Middle Aged; Organoplatinum Compounds; Ovarian Neoplasms; Pilot Projects

1988
Potent Chlorambucil-Platinum(IV) Prodrugs.
    International journal of molecular sciences, 2022, Sep-09, Volume: 23, Issue:18

    Topics: Antineoplastic Agents; Carboplatin; Cell Line, Tumor; Chlorambucil; Cisplatin; Female; Humans; Male; Organoplatinum Compounds; Ovarian Neoplasms; Oxaliplatin; Platinum; Prodrugs; Reactive Oxygen Species

2022